Mesenchymal stem cells overexpressing ephrin-B2 rapidly adopt an early endothelial phenotype with simultaneous reduction of osteogenic potential

Tissue Engineering - Part A

Volumn 16, Issue 9, 2010, Pages 2755-2768

  Duffy, Garry P ^a,b   D'Arcy, Sinead ^a   Ahsan, Tabassum ^b   Nerem, Robert M ^b   O'Brien, Timothy ^a   Barry, Frank ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MEMBRANES; DISEASE CONTROL; ELECTRIC IMPEDANCE; ENDOTHELIAL CELLS; FLOWCHARTING; GENETIC ENGINEERING; HISTOLOGY; PEPTIDES; SELF ASSEMBLY; STEM CELLS; TISSUE;

ANGIOGENESIS; CARDIO-VASCULAR DISEASE; CELL SOURCES; CELL SURFACES; CLINICAL TRIAL; CYTOKINES; GENETIC MODIFICATIONS; GENETICALLY MODIFIED; ISCHEMIC TISSUES; MESENCHYMAL STEM CELL; MORTALITY RATE; NEOVASCULARIZATION; NUCLEOFECTION; OSTEOGENIC POTENTIAL; OVER-EXPRESSION; PLATELET-DERIVED GROWTH FACTORS; PRECLINICAL STUDIES; PRO-ANGIOGENIC THERAPIES; SIMULTANEOUS REDUCTION; STEM CELL THERAPY; VASCULAR DEVELOPMENT; VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULAR SUPPLY; VESSEL DEVELOPMENT; VESSEL-LIKE STRUCTURES; VON WILLEBRAND FACTOR;

CELL CULTURE;

EPHRIN B2; PLATELET DERIVED GROWTH FACTOR; VASCULOTROPIN A;

ARTICLE; BONE DEVELOPMENT; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; GENETICS; HUMAN; MESENCHYMAL STEM CELL; METABOLISM; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

CELL DIFFERENTIATION; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; EPHRIN-B2; HUMANS; MESENCHYMAL STEM CELLS; OSTEOGENESIS; PLATELET-DERIVED GROWTH FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77956074155     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2009.0623     Document Type: Article

References (51)

1. Sellke, F.W., and Simons, M. Angiogenesis in cardiovascular disease: current status and therapeutic potential. Drugs 58, 391, 1999.
2. Jain, R.K. Molecular regulation of vessel maturation. Nat Med 9, 685, 2003.
3. Carmeliet, P. Angiogenesis in life, disease and medicine. Nature 438, 932, 2005.
4. Fraisl, P., Mazzone, M., Schmidt, T., and Carmeliet, P. Regulation of angiogenesis by oxygen and metabolism. Dev Cell 16, 167, 2009.
5. Carmeliet, P. Angiogenesis in health and disease. Nat Med 9, 653, 2003.
6. Losordo, D.W., and Dimmeler, S. Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part I: angiogenic cytokines. Circulation 109, 2487, 2004.
7. Losordo, D.W., and Dimmeler, S. Therapeutic angiogenesis and vasculogenesis for ischemic disease: part II: cell-based therapies. Circulation 109, 2692, 2004.
8. Yau, T.M., Kim, C., Li, G., Zhang, Y., Fazel, S., Spiegelstein, D., Weisel, R.D., and Li, R.K. Enhanced angiogenesis with multimodal cell-based gene therapy. Ann Thorac Surg 83, 1110, 2007.
9. Orlic, D., Kajstura, J., Chimenti, S., Jakoniuk, I., Anderson, S.M., Li, B., Pickel, J., McKay, R., Nadal-Ginard, B., Bodine, D.M., Leri, A., and Anversa, P. Bone marrow cells regenerate infarcted myocardium. Nature 410, 701, 2001.
10. Pittenger, M.F., and Martin, B.J. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 95, 9, 2004.
11. Kinnaird, T., Stabile, E., Burnett, M.S., Shou, M., Lee, C.W., Barr, S., Fuchs, S., and Epstein, S.E. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 109, 1543, 2004.
12. Kinnaird, T., Stabile, E., Burnett, M.S., Lee, C.W., Barr, S., Fuchs, S., and Epstein, S.E. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 94, 678, 2004.
13. Ladage, D., Brixius, K., Steingen, C., Mehlhorn, U., Schwinger, R.H., Bloch, W., and Schmidt, A. Mesenchymal stem cells induce endothelial activation via paracine mechanisms. Endothelium 14, 53, 2007.
14. Nagaya, N., Fujii, T., Iwase, T., Ohgushi, H., Itoh, T., Ue-matsu, M., Yamagishi, M., Mori, H., Kangawa, K., and Ki-tamura, S. Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. Am J Physiol Heart Circ Physiol 287, H2670, 2004.
15. Katritsis, D.G., Sotiropoulou, P.A., Karvouni, E., Karabinos, I., Korovesis, S., Perez, S.A., Voridis, E.M., and Papamichail, M. Transcoronary transplantation of autologous mesenchy-mal stem cells and endothelial progenitors into infarcted human myocardium. Catheter Cardiovasc Interv 65, 321, 2005.
16. Shyu, K.G., Wang, B.W., Hung, H.F., Chang, C.C., and Shih, D.T. Mesenchymal stem cells are superior to angiogenic growth factor genes for improving myocardial performance in the mouse model of acute myocardial infarction. J Biomed Sci 13, 47, 2006.
17. Wu, Y., Chen, L., Scott, P.G., and Tredget, E.E. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells 25, 2648, 2007.
18. Au, P., Tam, J., Fukumura, D., and Jain, R.K. Bone marrow-derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature. Blood 111, 4551, 2008.
19. Tirziu, D., and Simons, M. Angiogenesis in the human heart: gene and cell therapy. Angiogenesis 8, 241, 2005.
20. Dzau, V.J., Gnecchi, M., and Pachori, A.S. Enhancing stem cell therapy through genetic modification. J Am Coll Cardiol 46, 1351, 2005.
21. Matsumoto, R., Omura, T., Yoshiyama, M., Hayashi, T., In-amoto, S., Koh, K.R., Ohta, K., Izumi, Y., Nakamura, Y., Akioka, K., Kitaura, Y., Takeuchi, K., and Yoshikawa, J. Vascular endothelial growth factor-expressing mesenchymal stem cell transplantation for the treatment of acute myo-cardial infarction. Arterioscler Thromb Vasc Biol 25, 1168, 2005.
22. Huang, S.D., Lu, F.L., Xu, X.Y., Liu, X.H., Zhao, X.X., Zhao, B.Z., Wang, L., Gong, D.J., Yuan, Y., and Xu, Z.Y. Transplantation of angiogenin- overexpressing mesenchymal stem cells synergistically augments cardiac function in a porcine model of chronic ischemia. J Thorac Cardiovasc Surg 132, 1329, 2006.
23. Yang, J., Zhou, W., Zheng, W., Ma, Y., Lin, L., Tang, T., Liu, J., Yu, J., Zhou, X., and Hu, J. Effects of myocardial transplantation of marrow mesenchymal stem cells transfected with vascular endothelial growth factor for the improvement of heart function and angiogenesis after myocardial infarction. Cardiology 107, 17, 2007.
24. Yau, T.M., Kim, C., Li, G., Zhang, Y., Weisel, R.D., and Li, R.K. Maximizing ventricular function with multimodal cell-based gene therapy. Circulation 112, I123, 2005.
25. Spiegelstein, D., Kim, C., Zhang, Y., Li, G., Weisel, R.D., Li, R.K., and Yau, T.M. Combined transmyocardial revascular-ization and cell-based angiogenic gene therapy increases transplanted cell survival. Am J Physiol Heart Circ Physiol 293, 43311, 2007.
26. Pasquale, E. Eph-Ephrin bidirectional signalling in physiology and disease. Cell 133, 38, 2008.
27. Kertesz, N., Krasnoperov, V., Reddy, R., Leshanski, L., Kumar, S.R., Zozulya, S., and Gill, P.S. The soluble extracellular domain of EphB4 (sEphB4) antagonizes EphB4-EphrinB2 interaction, modulates angiogenesis, and inhibits tumor growth. Blood 107, 2330, 2006.
28. Adams, R.H., Wilkinson, G.A., Weiss, C., Diella, F., Gale, N.W., Deutsch, U., Risau, W., and Klein, R. Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev 13, 295, 1999.
29. Wang, H.U., Chen, Z.F., and Anderson, D.J. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 93, 741, 1998.
30. Herbert, S.P., Huisken, J., Kim, T.N., Feldman, M.E., Houseman, B.T., Wang, R.A., Shokat, K.M., and Stainier, D.Y.R. Arterial-venous segregation by selective cell sprouting: an alternative mode of blood vessel formation. Science 326, 294, 2009.
31. Gerety, S.S., Wang, H.U., Chen, Z.F., and Anderson, D.J. Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development. Mol Cell 4, 403, 1999.
32. Adams, R.H., and Klein, R. Eph receptors and ephrin li-gands. Essential mediators of vascular development. Trends Cardiovasc Med 10, 183, 2000.
33. Foo, S.S., Turner, C.J., Adams, S., Compagni, A., Aubyn, D., Kogata, N., Lindblom, P., Shani, M., Zicha, D., and Adams, R.H. Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly. Cell 124, 161, 2006.
34. Hafner, C., Meyer, S., Hagen, I., Becker, B., Roesch, A., Landthaler, M., and Vogt, T. Ephrin-B reverse signaling induces expression of wound healing associated genes in IEC-6 intestinal epithelial cells. World J Gastroenterol 11, 4511, 2005.
35. Erber, R., Eichelsbacher, U., Powajbo, V., Korn, T., Djonov, V., Lin, J., Hammes, H.P., Grobholz, R., Ullrich, A., and Vajkoczy, P. EphB4 controls blood vascular morphogenesis during postnatal angiogenesis. EMBO J 25, 628, 2006.
36. Mansson-Broberg, A., Siddiqui, A., Genander, M., Grinne-ma, K., Hao, X., Andersson, A., Wardell, E., Sylven, C., and Corbascio, M. Modulation of EphrinB2 leads to increased angiogenesis in ischemic myocardium and endothelial cell proliferation. Biochem Biophys Res Commun 373, 355, 2008.
37. Katsu, M., Koyama, H., Maekawa, H., Kurihara, H., Ucida, H., and Hamada, H. Ex vivo gene delivery of ephrin-B2 induces development of functional collateral vessels in a rabbit model of hind limb ischemia. J Vasc Surg 49, 192, 2009.
38. Murphy, J.M., Fink, D.J., Hunziker, E.B., and Barry, F.P. Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum 48, 3464, 2003.
39. Jaiswal, N., Haynesworth, S.E., Caplan, A.I., and Bruder, S.P. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem 64, 295, 1997.
40. Aslan, H., Zilberman, Y., Arbeli, V., Sheyn, D., Matan, Y., Liebergall, M., Li, J.Z., Helm, G.A., Gazit, D., and Gazit, Z. Nucleofection-based ex vivo nonviral gene delivery to human stem cells as a platform for tissue regeneration. Tissue Eng 12, 877, 2006.
41. Haleem-Smith, H., Derfoul, A., Okafor, C., Tuli, R., Olsen, D., Hall, D.J., and Tuan, R.S. Optimization of high-efficiency transfection of adult human mesenchymal stem cells in vitro. Mol Biotechnol 30, 9, 2005.
42. Zhang, S., Jiang, T., and Liang, M. Expression of Eph B4 and Ephrin B2 in cervical cancer tissues and angiogenesis. Int J Gynaecol Obstet 96, 46, 2007.
43. Epstein, S.E., Stabile, E., Kinnaird, T., Lee, C.W., Clavijo, L., and Burnett, M.S. Janus phenomenon: the interrelated tradeoffs inherent in therapies designed to enhance collateral formation and those designed to inhibit atherogenesis. Circulation 109, 2826, 2004.
44. Tahvanainen, J., Pykalainen, M., Kallonen, T., Lahteenmaki, H., Rasool, O., and Lahesmaa, R. Enrichment of nucleo-fected primary human CD4\+ T cells: a novel and efficient method for studying gene function and role in human primary T helper cell differentiation. J Immunol Methods 310, 30, 2006.
45. Zhao, C., Irie, N., Takada, Y., Shimoda, K., Miyamoto, T., Nishiwaki, T., Suda, T., and Matsuo, K. Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis. Cell Metab 4, 111, 2006.
46. Mundy, G.R., and Elefteriou, F. Boning up on ephrin signaling. Cell 126, 441, 2006.
47. Liu, J.W., Dunoyer-Geindre, S., Serre-Beinier, V., Mai, G., Lambert, J.F., Fish, R.J., Pernod, G., Buehler, L., Bouna-meaux, H., and Kruithof, E.K. Characterization of endothe-lial-like cells derived from human mesenchymal stem cells. J Thromb Haemost 5, 826, 2007.
48. Duffy, G., Ahsan, T., O'Brien, T., Barry, F., and Nerem, N. Bone marrow-derived mesenchymal stem cells promote angiogenic processes in a time-and dose-dependent manner in vitro. Tissue Eng Part A 15, 2459, 2009.
49. Oswald, J., Boxberger, S., Jorgensen, B., Feldmann, S., Eh-ninger, G., Bornhauser, M., and Werner, C. Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem cells (Dayton, Ohio) 22, 377, 2004.
50. Ventura, C., Cantoni, S., Bianchi, F., Lionetti, V., Cavallini, C., Scarlata, I., Foroni, L., Maioli, M., Bonsi, L., Alviano, F., Fossati, V., Bagnara, G.P., Pasquinelli, G., Recchia, F.A., and Perbellini, A. Hyaluronan mixed esters of butyric and retinoic Acid drive cardiac and endothelial fate in term placenta human mesenchymal stem cells and enhance cardiac repair in infarcted rat hearts. J Biol Chem 282, 14243, 2007.
51. Griffith, L.G., and Swartz, M.A. Capturing complex 3D tissue physiology in vitro. Nat Rev Mol Cell Biol 7, 211, 2006.